Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes

BackgroundRecent studies supported associations between four NMDA-receptor-mediated signalling genes (D-amino acid oxidase, DAO; D-amino acid oxidase activator, DAOA; protein phosphatase 3 catalytic subunit gamma isoform, PPP3CC; dystrobrevin-binding protein 1, DTNBP1) and schizophrenia susceptibility, even though with contrasting results.MethodsIn an attempt to replicate these findings for the first time in an Italian population, a panel of 32 tagSNPs was analysed in a representative case-control sample involving 879 subjects.ResultsAn association in the allele frequency was observed for the estimated PPP3CC CAG triplotype in the SNP window rs4872499 T/C-rs11780915 A/G-rs13271367 G/A (pcorrect = 0.001). Similarly, the clustered genotype frequencies of the estimated/phased CAG triplotype differed between cases and controls (p = 0.004), with the carriers having a higher frequency in the control population (p = 0.002, odd ratio OR = 0.59, 95% confident interval CI: 0.43-0.82).Following the phenotypic dissection strategy, the analysis of single SNPs evidenced a protective effect in males of rs11780915 and rs13271367 in PPP3CC gene (pcorrect = 0.02, pcorrect = 0.04 respectively). Moreover the estimated/phased GT diplotype (rs2070586A/G-rs3741775G/T) carriers of the DAO gene were more highly represented in female controls (p = 0.017, OR = 0.58, 95% CI: 0.37-0.90), as were the estimated/phased CAG triplotype carriers of the PPP3CC gene in females (p = 0.01, OR = 0.53, 95% CI: 0.32-0.87). In addition, we performed an interaction analysis, and a 66% (p = 0.003, OR = 0.34, 95% CI: 0.17-0.70) lower risk of developing schizophrenia for female (CAG + GT) carriers versus non-CAG or -GT carriers was observed. For DTNBP1, we found a protective effect in males for the rs6459409 (pcorrect = 0.02) and the estimated/phased CT diplotype (rs6459409-rs9476886) carriers (p = 3x10-4, OR = 0.46, 95% CI: 0.30-0.70).In relation to diagnostic subtypes, the estimated/phased DAO GT diplotype and PPP3CC CAG triplotype female carriers were found to show relative risk ratio (RRR) values of 0.52 and 0.54 lower risk for a paranoid phenotype respectively.ConclusionsAlthough the results are preliminary and needed replication in a larger sample, this study suggests that NMDA receptor-mediated signalling genes (DAO, PPP3CC, DTNBP1) might be involved in schizophrenia pathogenic mechanisms related to gender.

[1]  Y. Fang,et al.  Lack of effect of brain derived neurotrophic factor (BDNF) Val66Met polymorphism on early onset schizophrenia in Chinese Han population , 2011, Brain Research.

[2]  T. Hergueta,et al.  The mini international neuropsychiatric interview , 1998, European Psychiatry.

[3]  K. Ohi,et al.  No association between DAO and schizophrenia in a Japanese patient population: A multicenter replication study , 2010, Schizophrenia Research.

[4]  G. Pearlson,et al.  Sex differences in schizophrenia. , 1997, Archives of general psychiatry.

[5]  D. Rujescu,et al.  Genetic findings in schizophrenia patients related to alterations in the intracellular Ca-homeostasis , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[6]  Michele Tansella,et al.  Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[7]  Jianxin Shi,et al.  No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. , 2008, The American journal of psychiatry.

[8]  M. Abney,et al.  The sex-specific genetic architecture of quantitative traits in humans , 2006, Nature Genetics.

[9]  G. Racagni,et al.  Association Study of –1727 A/T, –50 C/T and (CAA)n Repeat GSK-3β Gene Polymorphisms with Schizophrenia , 2004, Neuropsychobiology.

[10]  T. Kuno,et al.  Association of calcineurin A gamma subunit (PPP3CC) and early growth response 3 (EGR3) gene polymorphisms with susceptibility to schizophrenia in a Japanese population , 2011, Psychiatry Research.

[11]  John P A Ioannidis,et al.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database , 2008, Nature Genetics.

[12]  S. Lawrie,et al.  Associative learning and the genetics of schizophrenia , 2009, Trends in Neurosciences.

[13]  J. Meador-Woodruff,et al.  Role of glutamate in schizophrenia: integrating excitatory avenues of research , 2008, Expert review of neurotherapeutics.

[14]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[15]  Daniel L. Koller,et al.  Genome-Wide Association of Bipolar Disorder Suggests an Enrichment of Replicable Associations in Regions near Genes , 2011, PLoS genetics.

[16]  B. Turetsky,et al.  Reduced posterior nasal cavity volume: A gender-specific neurodevelopmental abnormality in schizophrenia , 2007, Schizophrenia Research.

[17]  Daniel L. Koller,et al.  Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction , 2012, Molecular Psychiatry.

[18]  Elliot S. Gershon,et al.  Allelic association of G72/G30 with schizophrenia and bipolar disorder: A comprehensive meta-analysis , 2008, Schizophrenia Research.

[19]  P. Pasqualetti,et al.  -G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study , 2007, Brain, Behavior, and Immunity.

[20]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[21]  Brien P. Riley,et al.  Allelic Heterogeneity in Genetic Association Meta-Analysis: An Application to DTNBP1 and Schizophrenia , 2009, Human Heredity.

[22]  Paul J. Harrison,et al.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.

[23]  J. Kowalski,et al.  Association Study Between BDNF C-281A Polymorphism and Paranoid Schizophrenia in Polish Population , 2011, Journal of Molecular Neuroscience.

[24]  E. Sacchetti,et al.  Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[25]  Paul J. Harrison,et al.  Erratum: Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence (Molecular Psychiatry (2005) 10 (40-68) DOI:10.1038/sj.mp.4001558)) , 2005 .

[26]  E. Stip,et al.  Sexual dimorphism in schizophrenia: is there a need for gender-based protocols? , 2011, Expert review of neurotherapeutics.

[27]  M. First,et al.  Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet , 1997 .

[28]  Elliot S. Gershon,et al.  Genetic associations with schizophrenia: Meta-analyses of 12 candidate genes , 2008, Schizophrenia Research.

[29]  K. Ben Salem,et al.  Association of the Met-196-Arg Variation of Human Tumor Necrosis Factor Receptor 2 (TNFR2) with Paranoid Schizophrenia , 2011, Journal of Molecular Neuroscience.

[30]  K. Song,et al.  Sex-different association of DAO with schizophrenia in Koreans , 2010, Psychiatry Research.

[31]  N. Volkow,et al.  Laterality patterns of brain functional connectivity: gender effects. , 2012, Cerebral cortex.

[32]  No association between PPP3CC and schizophrenia in the Chinese population , 2007, Schizophrenia Research.

[33]  A. Mendrek.  Reversal of normal cerebral sexual dimorphism in schizophrenia: evidence and speculations. , 2007, Medical hypotheses.

[34]  D. Blackwood,et al.  The PDE4B gene confers sex-specific protection against schizophrenia , 2007, Psychiatric genetics.

[35]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[36]  T. Kudo,et al.  Association study of the G72 gene with schizophrenia in a Japanese population: A multicenter study , 2009, Schizophrenia Research.

[37]  P. Pregelj.  Neurobiological aspects of psychosis and gender. , 2009, Psychiatria Danubina.

[38]  L. Lv,et al.  Association study of myelin transcription factor 1‐like polymorphisms with schizophrenia in Han Chinese population , 2012, Genes, brain, and behavior.

[39]  Francisco M. de la Vega,et al.  A Tool for Selecting SNPs for Association Studies Based on Observed Linkage Disequilibrium Patterns , 2005, Pacific Symposium on Biocomputing.

[40]  W. A. Fogel.  Diamine oxidase (DAO) and female sex hormones , 2005, Agents and Actions.

[41]  Patrick F. Sullivan,et al.  Genetic architectures of psychiatric disorders: the emerging picture and its implications , 2012, Nature Reviews Genetics.

[42]  U. Bachrach,et al.  Effects of testosterone and 17, β– estradiol on the polyamine metabolism in cultivated normal rat kidney epithelial cells , 2000, Amino Acids.